SM-Youtube

1

Epidemiology and risk profile of heart failure.

Bui AL, Horwich TB, Fonarow GC. Bui AL, et al. Among authors: fonarow gc. Nat Rev Cardiol. 2011 Jan;8(1):30-41. doi: 10.1038/nrcardio.2010.165. Epub 2010 Nov 9. Nat Rev Cardiol. 2011. PMID: 21060326 Free PMC article. Review.

2

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.

Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, Tillisch JH, Walden JA, Albanese E. Fonarow GC, et al. J Am Coll Cardiol. 1992 Mar 15;19(4):842-50. doi: 10.1016/0735-1097(92)90529-v. J Am Coll Cardiol. 1992. PMID: 1545080 Free article. Clinical Trial.

3

Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation.

Steimle AE, Stevenson LW, Fonarow GC, Hamilton MA, Moriguchi JD. Steimle AE, et al. Among authors: fonarow gc. J Am Coll Cardiol. 1994 Mar 1;23(3):553-9. doi: 10.1016/0735-1097(94)90735-8. J Am Coll Cardiol. 1994. PMID: 8113533 Free article.

4

Impact of left ventricular cavity size on survival in advanced heart failure.

Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Walden JA. Lee TH, et al. Among authors: fonarow gc. Am J Cardiol. 1993 Sep 15;72(9):672-6. doi: 10.1016/0002-9149(93)90883-e. Am J Cardiol. 1993. PMID: 8249843

5

Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Saxon LA, Stevenson WG, Middlekauff HR, Fonarow G, Woo M, Moser D, Stevenson LW. Saxon LA, et al. Am J Cardiol. 1993 Jul 1;72(1):62-5. doi: 10.1016/0002-9149(93)90220-7. Am J Cardiol. 1993. PMID: 8517430

6

Predictors of natural killer cell-mediated cytotoxicity deficiency in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

Doering LV, Vredevoe DL, Woo MA, Fonarow GC, Skotsko C, Bonavida B. Doering LV, et al. Among authors: fonarow gc. Am J Cardiol. 1997 Jul 15;80(2):234-6. doi: 10.1016/s0002-9149(97)00332-9. Am J Cardiol. 1997. PMID: 9230174

7

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.

Fonarow GC, Stevenson LW, Walden JA, Livingston NA, Steimle AE, Hamilton MA, Moriguchi J, Tillisch JH, Woo MA. Fonarow GC, et al. J Am Coll Cardiol. 1997 Sep;30(3):725-32. doi: 10.1016/s0735-1097(97)00208-8. J Am Coll Cardiol. 1997. PMID: 9283532 Free article.

8

Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.

Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A. Hamilton MA, et al. Among authors: fonarow gc. Am J Cardiol. 1998 Feb 15;81(4):443-7. doi: 10.1016/s0002-9149(97)00950-8. Am J Cardiol. 1998. PMID: 9485134 Clinical Trial.

9

Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

Vredevoe DL, Woo MA, Doering LV, Brecht ML, Hamilton MA, Fonarow GC. Vredevoe DL, et al. Among authors: fonarow gc. Am J Cardiol. 1998 Aug 1;82(3):323-8. doi: 10.1016/s0002-9149(98)00334-8. Am J Cardiol. 1998. PMID: 9708661

10

Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.

Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, Laks H, Wiener I. Fonarow GC, et al. Am J Cardiol. 2000 Apr 15;85(8):981-5. doi: 10.1016/s0002-9149(99)00914-5. Am J Cardiol. 2000. PMID: 10760339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

1,722 results

Search Page

Filters

My NCBI Filters

Search Results

1,722 results